REFERENCES
- Martidis A, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109: 920–927, [PUBMED], [INFOTRIEVE], [CSA]
- Jonas J B, et al. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol. 2003; 121: 57–61, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Martidis A, et al. Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol. 2001; 119: 1380–1383, [PUBMED], [INFOTRIEVE], [CSA]
- Antcliff R J, et al. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 2001; 108: 765–772, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Benhamou N, et al. Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol. 2003; 135: 246–249, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Jonas J B, et al. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2002; 240: 782–783, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Greenberg P B, et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol. 2002; 86: 247–248, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Penfold P L. Intravitreal triamcinolone in recurrence of choroidal neovascularization. Br J Ophthalmol. 2002; 86: 600–601, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Jonas J B, et al. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol. 2001; 131: 468–471, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Jonas J B, et al. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol. 2000; 84: 1064–1067, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Danis R P, et al. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000; 20: 244–250, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Jonas J B, et al. Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone. J Glaucoma. 2001; 10: 284–287, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Jonas J B, et al. Intravitreal injection of crystalline cortisone as adjunctive treatment of pre-phthisical hypotony. Graefes Arch Clin Exp Ophthalmol. 2001; 239: 464–465, [PUBMED], [INFOTRIEVE], [CSA]
- Roth D B, et al. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol. 2003; 121: 1279–1282, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sutter F KP, et al. Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol. 2003; 87: 972–974, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Moshfeghi D M, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection, Scientific poster 144. Annual Meeting of the American Academy of Ophthalmology, Orlando, Florida, 2002
- Benz M S, et al. Endophthalmitis cause by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone. Arch Ophthalmol. 2003; 121: 271–273, [PUBMED], [INFOTRIEVE], [CSA]
- Young S, et al. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol. 2001; 29: 2–6, [CROSSREF], [CSA]
- McCuen B W, II, et al. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol. 1981; 91: 785–788, [PUBMED], [INFOTRIEVE], [CSA]
- Jaffe G J, et al. Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device. Invest Ophthalmol Vis Sci. 2000; 41: 3569–3575, [PUBMED], [INFOTRIEVE], [CSA]
- Perry H D, et al. Intravitreal injections by a dermojet syringe. Ann Ophthalmol. 1977; 9: 737–740, [PUBMED], [INFOTRIEVE]
- Jonas J B, et al. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol. 2003; 87: 24–27, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wingate R J, et al. Intravitreal triamcinolone and elevated intraocular pressure. Aust NZ J Ophthalmol. 1999; 27: 431–432, [CROSSREF], [CSA]
- Jonas J B, et al. Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide. Arch Ophthalmol. 2003; 121: 729–730, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Schindler R H, et al. The clearance of intravitreal triamcinolone acetonide. Am J Ophthalmol. 1982; 93: 415–417, [PUBMED], [INFOTRIEVE]
- Scholes G N, et al. Clearance of triamcinolone from vitreous. Arch Ophthalmol. 1985; 103: 1567–1569, [PUBMED], [INFOTRIEVE]